Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

CD2BP3, CIN85 and the structurally related adaptor protein CMS bind to the same CD2 cytoplasmic segment, but elicit divergent functional activities.

Interaction trap cloning was used to identify a CD2 cytoplasmic tail-binding protein termed CD2BP3. CD2BP3 is the major RNA splice variant of the CIN85 locus in human T lymphocytes, lacking SH3A, the first of three SH3 domains found in CIN85, but retaining SH3B, SH3C, a proline-rich domain and C-terminal coiled coil. CD2BP3 has 35% amino acid identity to CMS, a structurally related protein binding to the same highly conserved segment of the CD2 tail and known to be involved in T cell polarization/cytoskeletal interactions. Unlike CMS, however, CD2BP3 does not co-localize with F-actin and binds p130(Cas) weakly, if at all. Moreover, CIN85/CD2BP3 proteins are readily degraded by TCR cross-linking, consistent with the presence of a PEST sequence C-terminal to SH3C. CIN85 SH3A and CIN85/CD2BP3 SH3B bind to proline-rich segments within CIN85/CD2BP3 themselves as evidenced by mAb accessibility analysis and protein interaction studies including c-Cbl binding. This form of intramolecular regulation is not manifest by CMS. CMS and CIN85 activities are antagonistic, while the functions of CIN85 and CD2BP3 are also distinct. Thus, CD2-mediated adhesion, signaling and cell motility are regulated in a highly complex manner.

Pubmed ID: 12618476


  • Tibaldi EV
  • Reinherz EL


International immunology

Publication Data

March 5, 2003

Associated Grants

  • Agency: NIAID NIH HHS, Id: AI 21226

Mesh Terms

  • Adaptor Proteins, Signal Transducing
  • Amino Acid Sequence
  • Antigens, CD2
  • Carrier Proteins
  • Crk-Associated Substrate Protein
  • Cytoskeletal Proteins
  • Cytoskeleton
  • Humans
  • Molecular Sequence Data
  • Phosphoproteins
  • Proteins
  • Retinoblastoma-Like Protein p130
  • Sequence Alignment
  • Sequence Analysis, Protein
  • T-Lymphocytes
  • Two-Hybrid System Techniques